Latest News

 Filter by Provider

Following Warren Buffett's advice may make sense for most investors.

Tango Therapeutics beat expectations Friday for its combination using Revolution Medicines' newly approved drug in pancreatic cancer.

More rate hikes are likely ahead. That may not necessarily mean doom for the S&P 500.

Card accounts stay open until someone calls the issuer. Learn who pays leftover balances, when family can be liable, and what to leave behind.

Intel can deliver stronger-than-expected results and guidance when it releases its Q3 earnings report on Oct. 29.

Waiting until 70 maximizes your monthly check, but the break-even math may surprise you.

Anthropic is getting ready to go public - valuation 2 trillion dollars. Official story: revenue is booming, growth is growing, and the business is finally

This company is entering a massive growth business, but investors didn't want to hear it.

One of these pharma stocks offers more income, but the other offers a safer dividend.

BlockchAIn Digital Infrastructure (NYSEAMERICAN:AIB) outlined its strategy to develop AI-focused data center capacity, emphasizing power availability, long-term customer contracts and project-level financing during a virtual roadshow led by CEO Jerry Tang and CFO Jolienne Halisky. Tang described th

A new high-water mark for Q3 revenue failed to impress investors.

The iShares Gold Trust and VanEck Gold Miners ETF offer two distinct ways to invest in gold, but their differences could have a significant impact on your portfolio.

Each stock will have a make-or-break moment soon.

Circle's stablecoin infrastructure is scaling fast, but Strategy's Bitcoin treasury strategy presents a radically different risk-reward equation for investors.

SK Hynix and Micron are both riding the memory supercycle, but they have important differences.

Nearly $116 billion of Berkshire’s invested assets can be traced to a trio of artificial intelligence (AI) pioneers.

ASML has underperformed the broader semiconductor sector, and a stock split could be just what the company needs right now.

Both memory stocks are sizzling hot this year, but one appears to be the better pick now.

Kearny Financial (NASDAQ:KRNY) shareholders elected four directors, ratified Crowe LLP as the company’s independent registered public accounting firm for fiscal 2027 and approved, on a non-binding advisory basis, executive compensation at the company’s annual meeting. The company said Theodore J. A

Astera Labs' sell-off last week may be a buying opportunity as its debt-free balance sheet, new PCIe 7 and Orion launches, and Nov. 3 earnings put its AI connectivity growth story in focus.

VYVGART revenue surged 54% year-over-year amid strategic Forte Biosciences acquisition.

Target's dividend is benefiting from high-margin revenue from advertising and memberships.

The newest inflation update offers a double whammy for the stock market.

These companies make up about 20% of the index.

The move offers Meta valuable flexibility.

Afya (NASDAQ:AFYA) outlined its strategy for expanding its healthcare education and digital-services ecosystem at its 2026 Afya Day, with executives emphasizing a proposed merger with Yduqs, planned synergy capture, shareholder returns and new growth avenues in medical education and physician-focuse

The software slowdown that kept me out of the stock just reversed. Is an unchanged revenue forecast reason to wait longer?

Cardano could be headed for a big comeback in 2027.

Tesla's third-quarter show the company is still struggling to grow.

Believing in a Bitcoin supercycle doesn't really change how to invest in it.

Here's how pharmaceutical stocks compare to biotech in terms of risk, rewards, and costs.

United Rentals’ third quarter results were driven by sustained momentum in large-scale projects across multiple end markets, supported by the company’s broad...

Wyndham’s third quarter results met Wall Street’s revenue expectations, but the market response was negative, with shares declining following the release. Ma...